STOCK TITAN

RLI Corp. Form 4 Filings

RLI NYSE

Every Form 4 that RLI Corp. (RLI) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow RLI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RLI filings page.

Rhea-AI Summary

RLI Corp director James Henderson Bradshaw reported an acquisition related to equity compensation. On 2026-08-13, he received 2,153 Restricted Stock Units, each representing one share of common stock, at a stated price of $0.00 per unit, bringing his directly held RSU-related position to 2,153 units. According to the terms, these restricted stock units are scheduled to vest 100% on the earlier of the RLI Corp. 2027 Annual Shareholders' Meeting or one year after the grant date.

Rhea-AI Summary

RLI Corp reported that Chief Legal Officer Jeffrey D. Fick received a grant of 7,500 stock options on August 3, 2026. The options have an exercise price of $61.29 per share, cover 7,500 shares of common stock, vest in 20% annual increments starting one year after the grant date, and expire on August 3, 2034. Following this grant, he holds 7,500 options directly.

Rhea-AI Summary

RLI Corp reported that Vice President, Controller Seth Anthony Davis received a grant of stock options covering 1,500 shares of Common Stock on 2026-08-03. The options have an exercise price of $61.29 per share, expire on 2034-08-03, and may be exercised in 20% annual increments starting 2027-08-03.

Rhea-AI Summary

RLI Corp reported that chief operating officer Jennifer L. Klobnak received a grant of 12,500 stock options on August 3, 2026. The options have an exercise price of $61.29 per share, vest in 20% annual increments starting one year after grant, and expire on August 3, 2034.

Rhea-AI Summary

RLI Corp reported that Chief Executive Officer Craig W. Kliethermes received a grant of stock options covering 22,500 shares of common stock at an exercise price of $61.29 per share. The options vest 20% after one year and 20% each year thereafter and expire on August 3, 2034.

Rhea-AI Summary

RLI Corp director Debbie Sharell Roberts indirectly acquired 408.2300 shares of common stock on 2026-07-31 at $61.2400 per share. The shares are held through a Directors' Trust, bringing her indirect holdings to 30401.9770 shares, adjusted for a 2-for-1 stock split and reflecting dividend reinvestment.

Rhea-AI Summary

RLI Corp director Paul Bennett reported an other acquisition of 470.8030 shares of common stock on 2026-07-31 at $61.2400 per share. The shares are held indirectly through a Directors' Trust, bringing that trust's holdings to 9,931.9000 shares. All share amounts are adjusted for a 2-for-1 stock split effective 01/15/25.

Rhea-AI Summary

RLI CORP director Angelina Michael E updated reported holdings of common stock as of June 30, 2026, without any coded buy or sell transactions. Indirect holdings through a Directors' Trust total 15,282.863 shares, and direct holdings total 25,585 shares. Footnotes state these amounts were adjusted for a 2-for-1 stock split on January 15, 2025 and reflect dividend reinvestment.

Rhea-AI Summary

RLI CORP chief executive officer Craig W. Kliethermes filed an amended insider report showing an open-market purchase of 5,000 shares of common stock at $52.00 per share. After this transaction, he directly holds 153,990 RLI shares, with ownership figures reflecting dividend reinvestment.

The filing is an amendment to correct the originally reported number of shares acquired on May 27, 2026, clarifying the size of the CEO’s recent personal share purchase.

Rhea-AI Summary

RLI CORP director buys additional shares on the open market. Director Clark C. Kellogg purchased 3,000 shares of RLI common stock in an open-market transaction at a price of $50.90 per share. After this purchase, Kellogg directly owns 4,502.163 shares of RLI common stock.

Rhea-AI Summary

RLI CORP director David B. Duclos made an open-market purchase of the company’s common stock. He bought 2,500 shares on May 28, 2026 at a price of $51.99 per share. After this transaction, he directly owns 9,780.16 shares, with ownership reflecting dividend reinvestment.

Rhea-AI Summary

RLI Corp Chief Executive Officer Craig W. Kliethermes reported an open-market purchase of 2,000 shares of RLI common stock at $52.00 per share. After this transaction, he directly owns 150,990 common shares. Footnotes note prior stock option adjustments for a 2-for-1 stock split and that ownership reflects dividend reinvestment.

Rhea-AI Summary

RLI Corp’s Chief Operating Officer Jennifer L. Klobnak made an open-market purchase of 2,000 shares of the company’s Common Stock at $52.72 per share. Following this transaction, she directly owns 104,318 shares of RLI Corp common stock.

Rhea-AI Summary

RLI Corp’s chief executive officer, Craig W. Kliethermes, bought 5,000 shares of RLI common stock in an open-market purchase at $52.00 per share. After this transaction, he directly owns 148,990 common shares. Footnotes note prior stock option adjustments for a 2-for-1 stock split and that ownership reflects dividend reinvestment.

Rhea-AI Summary

RLI Corp’s Chief Operating Officer Jennifer L. Klobnak made an open-market purchase of 2,000 shares of RLI common stock on May 19, 2026 at $53.42 per share. Following this buy, she directly holds 102,318 shares. Footnotes note prior 2-for-1 split adjustments and dividend reinvestment effects on the balance.

Rhea-AI Summary

RLI CORP reported that Chief Operating Officer Jennifer L. Klobnak received a grant of stock options covering 12,500 shares of RLI common stock. The options have an exercise price of $49.88 per share and expire on May 14, 2034. According to the award schedule, 20% of the aggregate shares become exercisable one year after the grant date and then in 20% increments each year thereafter. Following this compensation-related award, Klobnak holds 12,500 stock options directly.

Rhea-AI Summary

RLI Corp’s chief legal officer, Jeffrey D. Fick, received a grant of stock options covering 7,500 shares of common stock. The options carry an exercise price of $49.88 per share and expire on May 14, 2034. According to the vesting schedule, 20% of the options become exercisable one year after the grant date, with an additional 20% vesting on each anniversary thereafter until fully vested. This is a compensation-related award rather than an open-market purchase or sale.

Rhea-AI Summary

RLI CORP reported that Vice President and Controller Seth Anthony Davis received new equity awards. On May 14, 2026, he was granted 300 restricted stock units, each representing one share of common stock upon vesting, scheduled to vest 100% on the third anniversary of the grant date. He was also granted stock options on 1,500 shares of common stock at an exercise price of $49.88 per share. According to the option schedule, 20% of the options become exercisable one year from the grant date and an additional 20% each year thereafter.

Rhea-AI Summary

RLI CORP reported that Chief Financial Officer Aaron Paul Diefenthaler received a grant of stock options. The award covers 40,000 stock options for RLI common stock at an exercise price of $49.88 per share.

These options were granted as compensation and are exercisable on a schedule where 20% of the total can be exercised beginning one year after the grant date and an additional 20% in each following year. After this grant, Diefenthaler holds 40,000 stock options directly, with the options scheduled to expire on May 14, 2034.

Rhea-AI Summary

RLI Corp chief executive officer Craig W. Kliethermes reported a compensation-related stock option grant. He received options covering 22,500 shares of common stock at an exercise price of $49.88 per share. The options expire on May 14, 2034 and vest in 20% increments annually, beginning one year after the grant date.

Rhea-AI Summary

RLI CORP director Clark C. Kellogg reported routine equity compensation and related share movements. He received a grant of 2,506 restricted stock units (RSUs), each representing one share of common stock. These RSUs are scheduled to vest 100% on the earlier of the company’s 2027 annual shareholders’ meeting or one year after grant.

Kellogg also exercised 1,681 previously granted RSUs into 1,681 shares of common stock and, through a Directors' Trust, acquired an additional 68 shares attributable to accrued special and regular dividend equivalents on RSUs. Following these transactions, the Directors' Trust holds 1,749 shares of common stock.

Rhea-AI Summary

RLI Corp director Paul Bennett reported routine equity compensation and related transactions. He received a grant of 2,506 restricted stock units, which are scheduled to vest 100% on the earlier of the RLI Corp 2027 Annual Shareholders' Meeting or one year after the grant date.

Bennett also exercised 1,681 restricted stock units into an equal number of common shares and now holds 9,096.229 common shares indirectly through a Directors' Trust, with ownership reflecting dividend reinvestment. Following these moves, he holds 2,506 restricted stock units directly and no remaining units from the exercised grant.

Rhea-AI Summary

RLI CORP director Debbie Sharell Roberts reported routine equity compensation activity. She received a grant of 2,506 restricted stock units (RSUs) on May 14, 2026, which convert into an equal number of RLI common shares when they vest.

The filing shows she exercised 1,681 RSUs into 1,681 shares of common stock on May 13, 2026, fully exhausting that RSU award. After related transactions, a Directors' Trust associated with her holds 28,837.066 common shares, including 68 shares reflecting dividend reinvestment. The new 2,506 RSUs are scheduled to vest 100% at the earlier of the 2026 annual shareholders' meeting or one year from grant.

Rhea-AI Summary

RLI Corp director Susan S. Fleming reported routine equity compensation activity. She received a grant of 2,506 restricted stock units that convert into an equal number of common shares at vesting. On a separate date, 1,681 restricted stock units vested and were exercised into common stock, increasing indirect holdings in a Directors' Trust to 22,674.484 shares. No open‑market purchases or sales were reported.

Rhea-AI Summary

RLI Corp director Jordan W. Graham reported compensation-related equity activity. He received a grant of 2,506 restricted stock units, and separately exercised 1,681 restricted stock units into common shares. Following these transactions, an associated Directors' Trust holds 118,176.471 shares of common stock, including effects of dividend reinvestment.

Rhea-AI Summary

STONE MICHAEL J reported acquisition or exercise transactions in this Form 4 filing.

RLI Corp director Michael J. Stone reported equity compensation and related share movements. He received a grant of 2,506 restricted stock units, each representing one share of common stock. Separately, 1,681 restricted stock units vested into 1,681 common shares, and ownership also reflects 68 additional shares from dividend reinvestment.

After these transactions, Stone holds 433,315.5196 shares of RLI common stock directly and 2,506 unvested restricted stock units. The new restricted stock units are scheduled to vest 100% on the earlier of the company’s 2027 Annual Shareholders' Meeting or one year after the grant date. All activity reflects compensation, vesting and reinvestment rather than open-market buying or selling.

Rhea-AI Summary

RLI Corp director David B. Duclos reported routine equity compensation and related share movements. On May 14, 2026, he received a grant of 3,508 restricted stock units, which will vest 100% on the earlier of the 2027 annual shareholders' meeting or one year after grant.

On May 13, 2026, 2,353 restricted stock units vested into 2,353 shares of common stock, and 135 additional shares were acquired through dividend reinvestment in a Directors' Trust. Following these transactions, Duclos holds 18,522.6869 common shares indirectly through the Directors' Trust and 3,508 unvested restricted stock units directly.

Rhea-AI Summary

RLI Corp director Robert P. Restrepo Jr. reported routine equity compensation activity. On May 14, 2026, he received a grant of 2,506 restricted stock units (RSUs), scheduled to vest 100% on the earlier of the 2027 Annual Shareholders' Meeting or one year after grant.

On May 13, 2026, 1,681 RSUs vested and converted into 1,681 shares of common stock, and an additional 68 common shares were acquired from the vesting of accrued special and regular dividend equivalents on RSUs. Following these transactions, he directly holds 26,501 shares of common stock and 2,506 RSUs, with no sales reported.

Rhea-AI Summary

RLI CORP director Angelina Michael E reported compensation-related equity activity. She received a grant of 2,506 restricted stock units (RSUs), each representing a future right to common shares. She also exercised 1,681 RSUs into common stock and acquired 68 shares through dividend-related mechanisms, bringing her direct common stock holdings to 25,585 shares.

Rhea-AI Summary

RLI Corp vice president and controller Seth Anthony Davis reported routine equity compensation activity involving restricted stock units. On May 4, 2026, 300 restricted stock units vested into the same number of common shares, and 146 shares were delivered back to the company to satisfy tax obligations at $50.73 per share. An additional 29 common shares were acquired through vested accrued special and regular dividend equivalents tied to the restricted stock units. Following these transactions, Davis directly holds about 31,091 shares of RLI common stock. No open-market purchases or sales were reported in this filing.

Rhea-AI Summary

RLI Corp director Paul Bennett Medini reported an administrative stock allocation tied to a deferred compensation plan. A total of 507.05 shares of common stock, referenced at $51.77 per share, were allocated to a Directors' Trust under the RLI Corp. Non-Employee Directors Deferred Compensation Plan. Following this restructuring-type transaction, indirect holdings in the trust stand at 7,347.229 shares of RLI common stock. The filing characterizes the move as an “other” transaction rather than an open-market buy or sell.

Rhea-AI Summary

RLI CORP director-related entity reports restructuring transaction

A Directors' Trust associated with RLI CORP director Debbie Sharell Roberts reported an "other" Form 4 transaction in RLI common stock. The restructuring-type move covered 482.905 shares at $51.77 per share, leaving the trust holding 27,088.066 shares indirectly after the transaction.

Rhea-AI Summary

RLI CORP vice president and controller Seth Anthony Davis exercised 3,000 stock options for Common Stock and had shares withheld to cover taxes. He exercised options at $28.07 per share and 2,236 shares of Common Stock were disposed of at $51.77 per share for tax-withholding. Following these transactions, he holds 30,762.2874 shares of Common Stock directly, and the exercised option grant has been fully used.

Rhea-AI Summary

RLI Corp director Debbie Sharell Roberts, through a Directors' Trust, reported an indirect acquisition of 425.6044 shares of common stock on 02/02/2026 at $58.74 per share. The shares were allocated under the RLI Corp. Non-Employee Directors Deferred Compensation Plan.

Following this allocation, the Directors' Trust held a total of 26,536.1024 shares of RLI common stock. Reported holdings were adjusted for a 2-for-1 stock split on 01/15/25, and the ownership amount reflects dividend reinvestment.

Rhea-AI Summary

RLI Corp director Medini Paul Bennett reported an indirect acquisition of common stock through a Directors' Trust on February 2, 2026. The trust received 446.885 shares at $58.74 per share under the RLI Corp. Non-Employee Directors Deferred Compensation Plan, a non-cash allocation coded as "J." Following this transaction, the Directors' Trust held a total of 6,822.424 indirect shares of RLI common stock, reflecting adjustments for a prior 2-for-1 stock split and dividend reinvestment.

Rhea-AI Summary

RLI Corp director Susan S. Fleming reported a routine share allocation under a deferred compensation plan. On 02/02/2026, 489.445 shares of RLI common stock were allocated at $58.74 per share to a Directors' Trust, increasing the trust's indirect holdings to 20,871.1689 shares. The transaction was coded "J," indicating an acquisition under a compensation or similar arrangement, and reflects adjustments for a prior 2-for-1 stock split and ongoing dividend reinvestment.

Rhea-AI Summary

RLI Corp reported that officer Seth Anthony Davis, Vice President and Controller, received a grant of stock options on 02/02/2026. The award covers 1,250 stock options with an exercise price of $58.74 per share, each option linked to one share of common stock.

These options become exercisable under a schedule where 20% of the total grant vests one year after the grant date, and an additional 20% vests on each anniversary thereafter. The options are exercisable from 02/02/2027 and expire on 02/02/2034, and are held directly by Davis.

Rhea-AI Summary

RLI Corp reported that Chief Operating Officer Jennifer L. Klobnak received a stock option grant on 02/02/2026. The option covers 8,125 shares of common stock at an exercise price of $58.74 per share and is held as direct ownership.

The option becomes exercisable in stages. Starting one year from the grant date, 20% of the total shares may be exercised, with an additional 20% vesting each year thereafter in equal increments. The option is listed as exercisable beginning 02/02/2027 and expires on 02/02/2034.

Rhea-AI Summary

RLI Corp reported that Chief Legal Officer Jeffrey D. Fick received a grant of stock options for 3,750 shares of common stock on February 2, 2026. The options have an exercise price of $58.74 per share and were received at no cost to him.

According to the option schedule, 20% of the 3,750 options become exercisable one year after the grant date, with an additional 20% vesting each year in similar increments until fully vested. The options expire on February 2, 2034 if not exercised. Following this grant, Fick beneficially holds 3,750 derivative securities directly.

Rhea-AI Summary

RLI Corp's chief executive officer, Craig W. Kliethermes, received a new stock option award. On 02/02/2026, he was granted options to buy 15,000 shares of RLI common stock at an exercise price of $58.74 per share. The options were received at a price of $0 to him.

The options vest over time under a scheduled plan. Beginning one year after the grant date, 20% of the total options become exercisable each year, so the award vests in equal 20% increments over five years. The options are directly owned and are scheduled to expire on 02/03/2034.

Rhea-AI Summary

RLI Corp's chief executive officer, Craig W. Kliethermes, increased his direct ownership of the company’s common stock through a dividend reinvestment on January 23, 2026. The transaction involved the purchase of 5,000 shares of RLI common stock at a price of $57.45 per share, coded as an open-market or dividend-related purchase. Following this transaction, Kliethermes directly beneficially owns 143,990 shares of RLI common stock. A footnote explains that the reported ownership reflects dividend reinvestment, meaning cash dividends were automatically used to acquire additional shares rather than being taken in cash.

Rhea-AI Summary

RLI Corp's chief operating officer Jennifer L. Klobnak reported a purchase of 2,000 shares of RLI common stock. The transaction took place on January 23, 2026 at a price of $57.99 per share, according to the Form 4 filing. Following this purchase, she beneficially owned 100,318 shares of RLI common stock in direct ownership. A footnote explains that the reported balance reflects dividend reinvestment, indicating that part of the position has grown through automatic reinvestment of dividends over time.

Rhea-AI Summary

RLI Corp (RLI) insider Aaron P. Diefenthaler, Treasurer and Chief Investment Officer, reported option-related stock transactions. On 11/25/2025, he exercised 18,000 stock options for RLI common stock at an exercise price of $28.07 per share (transaction code M), increasing his common stock holdings. On the same date, he disposed of 12,376 shares at a price of $63.94 per share (transaction code F), typically indicating shares withheld or sold to cover taxes. After these transactions, he directly owned 71,762.5698 shares of RLI common stock, and the reported stock option position from this grant was reduced to 0 derivative securities.

The filing notes that share and option figures were adjusted for a 2-for-1 stock split on 01/15/2025 and that the option grant price was previously adjusted for a $7.00 extraordinary dividend declared 11/10/2022.

Rhea-AI Summary

RLI CORP reported an insider equity transaction by its Vice President and Controller. On 11/25/2025, the officer acquired 11,000 shares of common stock at $28.07 per share in connection with a stock option transaction coded “M.” On the same date, 7,563 shares of common stock were disposed of in a transaction coded “F” at $63.94 per share. After these transactions, the officer directly beneficially owned 29,998.2874 shares of RLI common stock and held 3,000 stock options with an exercise price of $28.07. The option terms reflect adjustments for a 2-for-1 stock split effective 01/15/25 and a $7.00 extraordinary dividend declared 11-10-2022, and vest in 20% annual increments starting one year from the 05/03/2019 grant date.

Rhea-AI Summary

RLI Corp reported an insider equity award. Chief Operating Officer Jennifer L. Klobnak acquired a stock option covering 8,125 shares at an exercise price of $58.66 per share on 11/03/2025. The option vests in 20% increments annually, beginning one year from the grant date, and expires on 11/03/2033. The filing shows the option was acquired at a price of $0 and is held directly.

Rhea-AI Summary

RLI Corp (RLI) reported a Form 4 showing its Chief Executive Officer received a stock option grant. On 11/03/2025, the CEO was granted options to purchase 15,000 shares of common stock at an exercise price of $58.66 per share.

The options vest in 20% annual increments, beginning one year from the grant date on 11/03/2026, and expire on 11/03/2033. Following the transaction, 15,000 derivative securities were beneficially owned in direct form.

Rhea-AI Summary

RLI Corp reported an insider equity award on a Form 4. An officer (Vice President, Controller) acquired a stock option covering 1,250 shares at an exercise price of $58.66 on November 3, 2025.

The option begins to vest on November 3, 2026, with 20% of the grant exercisable each year thereafter, and expires on November 3, 2033. Following the grant, 1,250 derivative securities were beneficially owned, held directly.

Rhea-AI Summary

RLI Corp reported an insider equity award on Form 4. Chief Legal Officer Jeffrey D. Fick received a grant of 3,750 stock options on 11/03/2025 with an exercise price of $58.66 per share. The options cover 3,750 shares of common stock, begin to vest at 20% per year starting 11/03/2026, and carry an expiration date of 11/03/2033. Following the grant, 3,750 derivative securities were beneficially owned directly.

Rhea-AI Summary

RLI Corp reported an insider equity award. The company’s Chief Financial Officer received a stock option grant for 6,250 shares at an exercise price of $58.66 on 11/03/2025.

The option vests in 20% increments each year starting 11/03/2026 and expires on 11/03/2033. After the grant, 6,250 derivative securities were beneficially owned, held directly.

Rhea-AI Summary

RLI Corp (RLI) reported an insider transaction by a director. On 10/31/2025, the director acquired 424.016 shares of common stock, coded J, at $58.96 per share.

Following the transaction, the director beneficially owned 25,278.657 shares held indirectly through a Directors' Trust. The filing notes the shares were allocated under the RLI Corp. Non-Employee Directors Deferred Compensation Plan, with figures adjusted for a 2-for-1 stock split effective 01/15/2025 and reflecting dividend reinvestment.